[Effect of clofibrate therapy on the glucagon and insulin secretion as well as on the glucose tolerance in patients with type IV hyperlipoproteinemia].
D002994:Clofibrate / Q000627:therapeutic use*; D005934:Glucagon / Q000378:metabolism; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion
D007328:Insulin; D005934:Glucagon; D002994:Clofibrate
Einfluss einer Clofibrattherapie auf die Glukagon-, Insulinsekretion sowie Glukosetoleranz bei Patienten mit Hyperlipoproteinämie Typ IV.